domperidone has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Domperidone: A specific blocker of dopamine receptors. It speeds gastrointestinal peristalsis, causes prolactin release, and is used as antiemetic and tool in the study of dopaminergic mechanisms.
domperidone : 1-[3-(Piperidin-1-yl)propyl]-1,3-dihydro-2H-benzimidazol-2-one in which the 4-position of the piperidine ring is substituted by a 5-chloro-1,3-dihydro-2H-benzimidazol-2-on-1-yl group. A dopamine antagonist, it is used as an antiemetic for the short-term treatment of nausea and vomiting, and to control gastrointestinal effects of dopaminergic drugs given in the management of parkinsonism. The free base is used in oral suspensions, while the maleate salt is used in tablet preparations.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rabanal Basalo, A | 1 |
| Navarro Pablos, M | 1 |
| Viejo Pinero, N | 1 |
| Vila Méndez, ML | 1 |
| Molina Barcena, V | 1 |
| Montilla Bernabé, A | 1 |
| Villanueva Morán, MDP | 1 |
| Blanco Gallego, AM | 1 |
| Guirao Sánchez, C | 1 |
| Juárez Antón, S | 1 |
| Fernández Rodríguez, Á | 1 |
| Revuelta Puigdollers, ML | 1 |
| Sarriá Sánchez, MT | 1 |
| Martín Alegre, C | 1 |
| Martínez Álvarez, MÁ | 1 |
| Mestre de Juan, M | 1 |
| Mielgo Salvador, R | 1 |
| Gijón Seco, MT | 1 |
| Saníger Herrera, JM | 1 |
| Rodríguez Jiménez, ME | 1 |
| Navas de la Peña, B | 1 |
| Santa Cruz Hernández, J | 1 |
| Abad Esteban, AM | 1 |
| Díaz Martín, R | 1 |
| García Pérez, L | 1 |
| Herrero Vanrell, P | 1 |
| Arias de Saavedra Criado, MI | 1 |
| Vaquero Vinent, A | 1 |
| López Gómez, V | 1 |
| Montegrifo Rentero, VM | 1 |
| Simón Miguel, L | 1 |
| Campo Martos, I | 1 |
| Ortiz Zamorano, S | 1 |
| Izquierdo Zamarriego, MJ | 1 |
| Vázquez Carrión, I | 1 |
| López Valero, RM | 1 |
| Gil, C | 1 |
| Martínez, A | 1 |
| Soler López, B | 1 |
1 trial available for domperidone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
A randomized, double-blind study on the efficacy of oral domperidone versus placebo for reducing SARS-CoV-2 viral load in mild-to-moderate COVID-19 patients in primary health care.
Topics: Antiviral Agents; COVID-19; Domperidone; Double-Blind Method; Humans; Primary Health Care; SARS-CoV- | 2023 |